NATIONAL HEALTH INVESTORS INC (NHI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
NATIONAL HEALTH INVESTORS INC (NHI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 exhibit101cicsiefert.htm EX-10.1 Document Exhibit 10.1 CHANGE IN CONTROL SEVERANCE AGREEMENT THIS CHANGE IN CONTROL SEVERANCE AGREEMENT (this "Agreement") is entered into as of July I , 2026 (the " Effective Date") , by and between National Health Investors, Inc. , a Ma
How this was made
The 30-second read
Why it matters
This disclosure updates NHI’s executive compensation arrangements for potential change-in-control scenarios, defining what constitutes a change in control and related terms (e.g., ownership/control/asset sale/liquidation triggers).
Market read
Primarily governance/compensation information; absent deal activity or quantified financial impact in the excerpt, it is unlikely to drive a major trading decision by itself.
What to watch
If the agreement includes unusually rich severance or broad change-in-control definitions, it could matter for long-dated risk pricing—however the provided excerpt does not include payout amounts or specific officer departure/election details beyond the agreement framework.
Background
The SEC 8-K (Item 5.02) attaches a change-in-control severance agreement between National Health Investors, Inc. and executive Todd Siefert, effective July 1, 2026.
Ticker impact
NHI filed an 8-K detailing a change-in-control severance agreement with executive Todd Siefert, including defined triggers and termination framework.
Likely limited near-term price impact; any effect would be via investor perception of governance/contract costs rather than operating fundamentals.
The text is an SEC 8-K exhibit describing severance terms and definitions, without disclosed financial magnitude, guidance, or an immediate corporate event like an acquisition or resignation.
Market effects
Minimal; change-in-control severance terms are company-specific and typically do not reset sector expectations.
None indicated.
None indicated.
Counterpoint
Traders may overreact to executive-compensation headlines; without deal/termination details or quantified payouts, the market signal is usually weak.
Key entities
- companyNational Health Investors, Inc.
Subject of the SEC 8-K filing describing change-in-control severance arrangements.
- executiveTodd Siefert
Named executive party to the change-in-control severance agreement.
